Thursday, November 17, 2005
Print Current Day:
|
|
SESSION I SCHEDULE | |
SESSION I:
DEVELOPMENTS IN LYSIS, MECHANICAL CLOT REMOVAL AND NEW TREATMENTS FOR ARTERIAL THROMBI, DVT AND VENOUS DISEASE (7-MINUTE TALKS)
Moderators:Frank J. Veith, M.D.
|
|
x | |
6:30 AM - 6:35 AM | Opening Remarks |
Presenters: Frank J. Veith, M.D. | |
6:35 AM - 6:42 AM | Modern Treatment Of Axillary Subclavian Vein DVT |
Presenters: Dennis F. Bandyk, M.D. | |
6:43 AM - 6:50 AM | A New Technique For The Treatment Of Subclavian Vein Thrombosis |
Presenters: Robert Lowe, M.D. | |
6:51 AM - 6:58 AM | Radiofrequency Ablation Of Varicose Veins: A Word Of Caution |
Presenters: Alan B. Lumsden, M.D., F.A.C.S. | |
6:59 AM - 7:06 AM | Angiojet Thrombectomy With A Distal Protection Device For Acute Limb Ischemia |
Presenters: Karthikeshwar Kasirajan, M.D. | |
7:07 AM - 7:14 AM | Isolated Thrombolysis For DVT Using The Trellis-8 System: Early Clinical Experience |
Presenters: Frank R. Arko, M.D. | |
7:15 AM - 7:22 AM | New Developments In The Endovascular Treatment Of DVT |
Presenters: Michael B. Silva, Jr., M.D. | |
7:23 AM - 7:30 AM | Venous Ulcers: What Really Works And What Doesn’t Based On Level I Evidence |
Presenters: Thomas F. O'Donnell, Jr., M.D. | |
7:30 AM - 7:40 AM | Panel Discussion |
END OF SESSION I | |
SESSION II SCHEDULE | |
SESSION II:
NEW DEVELOPMENTS IN VARICOSE VEIN TREATMENT (7-MINUTE TALKS)
|
|
x | |
7:40 AM - 7:47 AM | What’s The Story With Foam Sclerotherapy Of The Greater Saphenous Vein And Variceal Clusters: How To Do It, Does It Work And What Are The Complications? |
Presenters: John J. Bergan, M.D. | |
7:48 AM - 7:55 AM | Radiofrequency Versus Laser Versus Chemical Sclerotherapy For Endoablation Of The Saphenous Vein And When You Don’t Need To Do Stab Avulsions |
Presenters: Jose I. Almeida, M.D., F.A.C.S. | |
7:56 AM - 8:03 AM | New Developments In Sclerotherapy For Superficial Venous Disease: What Are The Legal Implications? |
Presenters: Lowell S. Kabnick, M.D., F.A.C.S. | |
8:04 AM - 8:11 AM | An International Experience Using The 980nm Laser: 7,000 Cases |
Presenters: Russell H. Samson, M.D., F.A.C.S., R.V.T. | |
8:12 AM - 8:19 AM | Percutaneous Ultrasound Guided Radiofrequency Ablation (VNUS) Can Be Used To Treat Perforator Incompetence: 1 Year Results And How To Do It |
Presenters: David W. Chang, M.D. | |
8:20 AM - 8:27 AM | Radiofrequency Ablation For Varicose Veins: Is It Effective? A Prospective Study Of 500 Patients |
Presenters: Cynthia K. Shortell, M.D. | |
8:28 AM - 8:35 AM | New Technologies For The Treatment Of Varicose Veins And Venous Reflux |
Presenters: Jeffrey L. Ballard, M.D., F.A.C.S. | |
8:35 AM - 8:45 AM | Panel Discussion |
END OF SESSION II | |
SESSION III SCHEDULE | |
SESSION III:
TOPICS OF INTEREST TO INTERVENTIONALISTS AND VASCULAR SURGEONS (7-MINUTE TALKS)
Moderators:Anton N. Sidawy, M.D., M.P.H.
|
|
x | |
8:45 AM - 8:52 AM | Possibilities In Interventional Therapy: What Are The Limits |
Presenters: John E. Abele | |
8:53 AM - 9:00 AM | Where Is Nanotechnology And Stent Technology Going? |
Presenters: Elliot L. Chaikof, M.D., Ph.D. | |
9:01 AM - 9:08 AM | Value And Limitations Of Drug Eluting Stents: What Is Their Potential? |
Presenters: Götz M. Richter, M.D., Ph.D. | |
9:09 AM - 9:16 AM | Nanoporous Stents Can Replace Polymer Covered Stents For Drug Delivery And Avoid Some Of The Problems |
Presenters: Mark H. Wholey, M.D. | |
9:17 AM - 9:24 AM | Percutaneous Heart Valves Are Feasible: Progress To Date |
Presenters: Martin B. Leon, M.D. | |
9:25 AM - 9:35 AM | Panel Discussion |
Moderator(s): Wesley S. Moore, M.D. / Thomas F. Panetta, M.D. | |
9:35 AM - 9:42 AM | Treatment For Complex Iliac Occlusions: When Is A Bypass Indicated? |
Presenters: Götz M. Richter, M.D., Ph.D. | |
9:43 AM - 9:50 AM | A Simplified Approach For Crossing Total Occlusions: Forget The New Gadgets, All You Need Is A Catheter And A Wire |
Presenters: Ali Amin, M.D., F.A.C.S., F.A.C.C., R.V.T. | |
9:51 AM - 9:58 AM | The UK Asymptomatic Carotid Surgery Trial (ACST): What Does It Tell Us About How We Should Treat Asymptomatic Carotid Bifurcation Disease? |
Presenters: Alison Halliday, M.S., F.R.C.S. | |
9:59 AM - 10:06 AM | Timing Of Complications During CAS: How Can They Be Predicted? |
Presenters: Piergiorgio Cao, M.D. | |
10:07 AM - 10:13 AM | Endovascular Treatment Of Traumatic Vascular Injuries |
Presenters: Michael B. Silva, Jr., M.D. | |
10:14 AM - 10:24 AM | Panel Discussion |
END OF SESSION III | |
SESSION IV SCHEDULE | |
SESSION IV:
NEW ADJUNCTS TO IMPROVE THE RESULTS OF BYPASSES, PTA AND STENTING (7-MINUTE TALKS)
Moderators:Götz M. Richter, M.D., Ph.D. / Lucien D. Castellani, M.D.
|
|
x | |
10:24 AM - 10:31 AM | What We Have Learned About Lower Extremity Occlusive Disease From The Prevent III And Prevent IV Trials With E2F Decoy |
Presenters: Michael S. Conte, M.D. | |
10:32 AM - 10:39 AM | Paclitaxel Anastomotic Wrap To Improve PTFE Femoropopliteal Patency: 1 Year Results Of A Randomized Prospective Study |
Presenters: Lindsay S. Machan, M.D. | |
10:40 AM - 10:47 AM | Why Ultrasonic Plaque Characteristics Predict Restenosis Of SFA Lesions: What To Do About Lesions With A High Chance Of Restenosis |
Presenters: Andrew N. Nicolaides, M.S., F.R.C.S. | |
10:48 AM - 10:55 AM | Value Of Duplex After PTA To Determine Need For Redilatation: What Is The Best Timing Of Duplex Studies After PTA? |
Presenters: Gregor D. Shanik, M.D. | |
10:56 AM - 11:03 AM | Does Laser Treatment Have A Role In Lower Extremity Ischemia After All? |
Presenters: Patrick Peeters, M.D. | |
11:04 AM - 11:12 AM | Panel Discussion |
END OF SESSION IV | |
SESSION V SCHEDULE | |
SESSION V:
A NEW CRITICAL LOOK AT CAROTID STENTING (CAS) AND EMBOLIC BRAIN PROTECTION DEVICES (7-MINUTE TALKS)
Moderators:Frank J. Veith, M.D.
|
|
x | |
11:12 AM - 11:19 AM | Carotid Echomorphology Correlates With Embolic Risk During CAS: Should Protection Devices Be Used Selectively? |
Presenters: Peter H. Lin, M.D. | |
11:20 AM - 11:27 AM | Debate: In CAS, Embolic Injury Is Not The Only Risk To The Brain |
Presenters: Sumaira Macdonald, MBChB (Comm), MRCP, FRCR, PhD | |
11:28 AM - 11:35 AM | Debate: In CAS, Embolic Injury To The Brain Is The Main Problem |
Presenters: Klaus D. Mathias, M.D. | |
11:36 AM - 11:43 AM | Hemodynamic Changes During CAS Cause Half The Complications: How Can They Be Prevented? |
Presenters: Marc R.H. van Sambeek, M.D., Ph.D. | |
11:44 AM - 11:51 AM | Debate: Why The 2-Year SAPPHIRE Trial Results Are So Good For CAS Enthusiasts |
Presenters: Kenneth Ouriel, M.D., F.A.C.S., F.A.C.C. | |
11:52 AM - 11:59 AM | Debate: Limitations To The Value Of The SAPPHIRE Trial |
Presenters: Peter R.F. Bell, M.D., F.R.C.S., D.S.C., K.B.E. | |
12:00 PM - 12:07 PM | Lessons Learned To Date From CREST: Why We Need The Randomized Phase Of CREST |
Presenters: Robert W. Hobson II, M.D. | |
12:08 PM - 1:08 PM | Lunch Break |
END OF SESSION V | |
SESSION VI SCHEDULE | |
SESSION VI:
UPDATE ON EVAR FOR AAAS: TRIALS, SURVEILLANCE AND MANAGEMENT OF COMPLICATIONS (7-MINUTE TALKS)
Moderators:Joseph L. Mills, M.D. / Gregorio A. Sicard, M.D.
|
|
x | |
1:08 PM - 1:15 AM | Mid-Term (Up To 3-Year) Results Of The Randomized Prospective DREAM Trial Comparing EVAR With Open AAA Repair: What Are The Implications? |
Presenters: Jan D. Blankensteijn, M.D. | |
1:16 PM - 1:23 PM | Do Results Of The EVAR Trials (I and II) Justify Endovascular Repair Of All AAAs In Patients With Suitable Anatomy? |
Presenters: Roger M. Greenhalgh, MD | |
1:24 PM - 1:31 PM | Don’t Assume AAA Growth After An Excluder Endograft Is Due To Permeability: AAA Enlargement In This Setting Is Multifactorial |
Presenters: Mark F. Fillinger, M.D. | |
1:32 PM - 1:39 PM | AAA Sac Wall Compliance: How To Measure It And Does It Predict Rupture Potential - Correlation With Finite Element Analysis |
Presenters: Mohan Adiseshiah, F.R.C.S. | |
1:40 PM - 1:47 PM | Dynamic CTA Can Assess Aneurysmal Wall Pulsatile Movement And Provide Information About Differences In Stent-Graft Performance And Effectiveness Of AAA Exclusion |
Presenters: Frans L. Moll, M.D., Ph.D. | |
1:48 PM - 1:55 PM | Volume Changes And Sac Pressure Correlations In Patients After EVAR |
Presenters: Jan S. Brunkwall, M.D., Ph.D. | |
1:56 PM - 2:03 PM | Proximal Attachment Failure Of AneuRx Endografts: How Can It Be Managed? |
Presenters: Mark A. Farber, M.D. | |
2:04 PM - 2:15 PM | Panel Discussion |
END OF SESSION VI | |
SESSION VII SCHEDULE | |
SESSION VII:
OTHER TOPICS OF INTEREST TO INTERVENTIONAL RADIOLOGISTS AND VASCULAR SURGEONS (7-MINUTE TALKS)
Moderators:Klaus D. Mathias, M.D. / Joseph L. Mills, M.D.
|
|
x | |
2:15 PM - 2:22 PM | Value Of Duplex Evaluation After Carotid Stenting (CAS) |
Presenters: Dennis F. Bandyk, M.D. | |
2:23 PM - 2:30 PM | Does Pathology Data Support The Value Of Cryoplasty And Absorbable Stents? |
Presenters: Renu Virmani, M.D. | |
2:31 PM - 2:38 PM | New Developments And Technical Advances In Renal Artery Stenting |
Presenters: Thomas A. Sos, M.D. | |
2:39 PM - 2:46 PM | BIVALIRUDIN (AngioMax): Is It A Better Anticoagulant For Peripheral Arterial Interventions? |
Presenters: Barry T. Katzen, M.D. | |
2:47 PM - 2:55 PM | Panel Discussion |
2:55 PM - 3:02 PM | All Metal Stents Are Not Alike In The SFA: What Is The Impact Of Stent Fractures And Will Biodegradable Stents Help? |
Presenters: Giancarlo Biamino, M.D. | |
3:03 PM - 3:10 PM | Update On Biodegradable (Biotronic) Metal Stents: Advantages And Limitations: Are They Better Than PTA Alone? |
Presenters: Marc Bosiers, M.D. | |
3:11 PM - 3:18 PM | Remote SFA Endarterectomy And Distal Aspire Stenting: Are The Multicenter Results Superior To SFA Stenting And Standard Bypasses? |
Presenters: David Rosenthal, M.D. | |
3:19 PM - 3:26 PM | 1 - 2 Year Results With SFA Atherectomy Using The SilverHawk Device: Why Are The Results Better Than Those Of Subintimal Angioplasty And Other Atherectomy Devices Including The Simpson Atherocath? |
Presenters: Venkatesh G. Ramaiah, M.D. | |
3:27 PM - 3:35 PM | Panel Discussion |
END OF SESSION VII | |
SESSION VIII SCHEDULE | |
SESSION VIII:
NEW DEVELOPMENTS IN ENDOVASCULAR ANEURYSM REPAIR AND TREATMENT OF COMPLICATIONS (7-MINUTE TALKS)
Moderators:Michael Lawrence-Brown, M.D., F.R.A.C.S.
|
|
x | |
3:35 PM - 3:42 PM | Are Newer 3rd Generation Stent-Grafts Safer And Better For EVAR? |
Presenters: Peter L. Harris, M.D., F.R.C.S. | |
3:43 PM - 3:50 PM | Update On Endovascular Repair Of Ruptured Aortic Aneurysms - Abdominal And Thoracic: The Collected World Experience |
Presenters: Frank J. Veith, M.D. | |
3:51 PM - 3:58 PM | Technical Details Which Make EVAR For Ruptured AAAs Easier And Safer |
Presenters: Mario Lachat, M.D. | |
3:59 PM - 4:06 PM | Does Suprarenal Fixation With Barbs Prevent Late Graft Migration: What Is The Effect On Renal Function? |
Presenters: Martin Malina, M.D., Ph.D. | |
4:07 PM - 4:14 PM | Transrenal Stent Placement In EVAR Is Not Harmful To The Kidneys: A 4-Year Controlled Study With The Powerlink Endograft |
Presenters: Jeffrey P. Carpenter, M.D. | |
4:15 PM - 4:25 PM | Panel Discussion |
Moderator(s): William D. Jordan, M.D. / Peter R.F. Bell, M.D., F.R.C.S., D.S.C., K.B.E. | |
4:25 PM - 4:32 PM | Fenestrated Aortic Endografts: What Are The Limitations And Complications? |
Presenters: Eric L.G. Verhoeven, M.D. | |
4:33 PM - 4:40 PM | Debate: Surgical Conversion Of Failed Endografts: When To Do It And How? |
Presenters: Elliot L. Chaikof, M.D., Ph.D. | |
4:41 PM - 4:48 PM | Debate: Failed Endografts After EVAR: When Should They Be Treated Endovascularly And When Open? |
Presenters: Jean-Pierre Becquemin, M.D., F.R.C.S. | |
4:49 PM - 4:56 PM | Debate: Reintervention For Failed EVAR: Open Conversion Is Almost Never Needed |
Presenters: Vicente Riambau, M.D., Ph.D. | |
4:57 PM - 5:04 PM | Type II Endoleaks After EVAR Are Not So Innocuous After All |
Presenters: Jean M. Panneton, M.D. | |
5:05 PM - 5:12 PM | Optimal Current Treatment For Type II Endoleaks: Is MRI Or MRA Helpful? |
Presenters: Richard A. Baum, M.D. | |
5:12 PM - 5:22 PM | Panel Discussion |
END OF SESSION VIII | |
SESSION IX SCHEDULE | |
SESSION IX:
UPDATES AND NEW CONCEPTS (7-MINUTE TALKS)
|
|
x | |
5:22 PM - 5:29 PM | What Is Happening In Myocyte And Stem Cell Transplantation: Progress And Limitations |
Presenters: Edward B. Diethrich, M.D. | |
5:30 PM - 5:37 PM | IV Sodium Bicarbonate Clearly Prevents Contrast Nephropathy: Technique Of Usage Based On A Randomized Prospective Study |
Presenters: Jeremiah H. Holleman, M.D. | |
5:38 PM - 5:45 PM | Is Incidental (“Drive By”) Renal Arteriography Justified In Patients With PVD Or Carotid Stenosis? |
Presenters: Mark R. Jackson, M.D. | |
5:46 PM - 5:53 PM | Crossing Total Occlusions: Technique And New Devices |
Presenters: Mark W. Mewissen, M.D. | |
5:54 PM - 6:01 PM | Microleaks, Ultrafiltration, And Endotension: What To Do About Them |
Presenters: Jon S. Matsumura, M.D. | |
6:02 PM - 6:09 PM | Minimally Invasive Monitoring Of AAA Sac Pressure After EVAR: State Of The Art |
Presenters: Takao Ohki, M.D. | |
6:10 PM - 6:17 PM | Reservations About The Value Of Monitoring AAA Intrasac Pressure |
Presenters: Geoffrey L. Gilling-Smith, M.S., F.R.C.S. | |
6:18 PM - 6:25 PM | Panel Discussion |
END OF SESSION IX | |
SESSION X SCHEDULE | |
SESSION X:
ISVS AWARD PAPERS (8-MINUTE TALKS)
|
|
x | |
6:25 PM - 6:33 PM | Vacuum Assisted Closure System With Direct Contact To Native Arteries And/Or Vascular Grafts To Improve The Outcome Of Perivascular Infection |
Presenters: Dieter O. Mayer, M.D. | |
6:34 PM - 6:42 PM | VNUS Is The Treatment Of Choice For Recurrent Long Saphenous Varicose Veins |
Presenters: Bruce D. Braithwaite, MChir, M.B. | |
6:43 PM - 6:51 PM | Preoperative Duplex Scanning And Intraoperative Direct Flow Correlation In Ischemic Lower Limb Revascularization |
Presenters: Fabio H. Rossi, M.D. | |
6:52 PM - 7:00 PM | A Comparison Of Open And Endovascular Abdominal Aortic Aneurysm Repair With Best Medical Treatment: Has The Availability Of EVAR Expanded Our Indications For Intervention And Improved Survival? |
Presenters: Niamh Hynes, M.D. | |
7:00 PM - 7:10 PM | Panel Discussion |
END OF SESSION X |